23andMe bankruptcy exposes genetic data risks: Customers’ DNA sold to foreign entities, including Russia
Once a leader in personalized health, 23andMe now faces bankruptcy, raising concerns about the genetic privacy of millions, as detailed by journalist Mike Adams.
Adams highlights risks of 23andMe’s data sales to entities like pharmaceutical firms and Russia’s Ministry of Defense,…
